So far, the malaria vaccine (RTS,S) has been successfully launched in three African countries countries, including Malawi, Ghana and Kenya
It's obvious that one of the leading causes of mortality in Africa is malaria, killing more people, including millions of children than many of the diseases ravaging Sub-Sahara Africa.
Perhaps the lasting solution to any disease is vaccination and in fact, this is true as far as the case of measles and small pox as well as many other notable diseases of public health significance are concerned. But as we knew it, there had never been any proven available vaccination against malaria until its first administration today in Kenya. Hence, the discovery of which is a giant stride.
Today, the WHO congratulated the government of Kenya for a successful launching of the world's first ever malaria vaccine, which took place firsthand in Home Bay County, Western Kenya.
According to the WHO, the vaccine is the first malaria vaccine to have proven to significantly reduce malaria in children, including life-threatening malaria. It was made known by the WHO that the vaccine will be made available to children from age 6 months in selected areas of the country in a phased pilot introduction.
The WHO regional director for Africa, Dr Matshidiso Moeti has said that the current pilot will provide WHO with key information and data for WHO policies on the broader use of the vaccine in Sub-Sahara Africa.
The vaccine administration will see to a collaboration of WHO with ministries of health in thee said countries, as well as partners such as PATH and GSK (the vaccine developer, which has donated up to10 million vaccine doses for the pilot program.)
The vaccine will be administered in four doses, with 3 doses between 6 months and 9 months of age and the 4th dose will be administration at age 2 years).
However, according to the WHO, these areas were selected firsthand because of the moderate to high rate of malaria in such areas
Source: The World Health Organization (WHO), 13th September, 2019.